Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

956 evidence items · page 24 / 39

0.66 %Among blood donors with multiple infections in Burkina Faso, the most common dual or triple combination was HBsAg-syphilis at 0.66%.

Burkina Fasohépatite B · syphilispublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

5 %Among HIV-negative women, the presence of abundant vaginal discharge was observed in 5.0%.

Burkina Fasoabundant vaginal dischargepublished 2011Journal of infection in developing countrieseurope_pmcdocument of 12 observationsDOI 10.3855/jidc.950

80 %Four out of five children ≥ 6 months were iron deficient.

Burkina Fasoanémiepublished 2021Maternal & child nutritioneurope_pmcdocument of 11 observations

0.84 visitsThe mean visit number on which the pLDH-based RDT was still positive after treatment was 0.84 visits with a 95% confidence interval of 0.55 to 1.1.

Burkina Fasopaludismepublished 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observations

84 %The HRP2-based RDT had sensitivity of 84.0% and specificity of 98.0% for P. falciparum.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

0.45 to_0.92The L1014F kdr mutation was detected in the two molecular forms of An. gambiae s.s. at varying frequencies (0.45 to 0.92).

Burkina Fasopaludismeobserved 2008published 2012Parasites & vectorseurope_pmcdocument of 5 observationsDOI 10.1186/1756-3305-5-127

90 %About 90% of malaria cases were diagnosed during and after the rainy season, between July and December.

Burkina Fasopaludismeobserved July to DecemberHAL · Unilimdocument of 83 observations

78 %In the rainy season, the RDT specificity for malaria infection was 78% in Burkina Faso.

Burkina Fasopaludismeobserved rainy seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192

11.21 %The overall prevalence of hepatitis B virus infection in Burkina Faso was 11.21%.

Burkina Fasohépatite Bpublished 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

1.7 %The risk of recurrent symptomatic malaria was 1.7% in the group given amodiaquine plus sulfadoxine-pyrimethamine and 10.2% in the group given artemether-lumefantrine.

Burkina Fasopaludismepublished 2007Lancet (London, England)europe_pmcdocument of 5 observations

94 %In the rainy season, the RDT sensitivity for malaria infection was 94% in Burkina Faso.

Burkina Fasopaludismeobserved rainy seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192

16 %Patients with non-active chronic hepatitis B represented 16.0% of the screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite Bobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations

0.24 %From 2003 to 2005, the number of confirmed yellow fever cases in Burkina Faso was respectively 1 out of 413 (0.24%), 14 out of 616 (2.27%), and 19 out of 618 (3.07%).

Burkina Fasofièvre jauneobserved 2003published 2010Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 5 observations

94.4 %The sensitivity of db-PCR-NALFIA compared to the initial diagnosis in the laboratory was 94.4%.

Burkina Fasopaludismepublished 2012Journal of clinical microbiologyeurope_pmcdocument of 10 observations

98.6 %Aedes aegypti constituted 98.60% of the Aedes spp. collected.

Burkina Fasoarbovirusespublished 2019Frontiers in veterinary scienceeurope_pmcdocument of 10 observationsDOI 10.3389/fvets.2019.00140

15 %The remaining 15% of the anti-CSP IgG was directed against minor-repeat sequences at D70 in Burkinabé adults vaccinated with ProC6C-AlOH/Matrix-M.

Burkina Fasopaludismeobserved D70HAL · Unilimdocument of 39 observations

Baseline CSP IgG levels are elevated in malaria cases than controls (p < 0.001).

Burkina Fasopaludismepublished 2019Nature communicationseurope_pmcdocument of 6 observations

63 %Bacterial DNA for germs causing purulent meningitis was identified in 108 out of 171 patients (63%) using real-time PCR.

Burkina Fasoméningite bactérienneobserved 2009–2010published 2013Medecine et sante tropicaleseurope_pmcdocument of 9 observations

22.6 %Malaria prevalence among febrile travellers in Burkina Faso was 22.6%.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

58.9 %The RDT-PfHRP2 had a specificity of 58.9% in diagnosing Plasmodium falciparum malaria in febrile children under 5 years of age in Burkina Faso in 2015.

Burkina Fasopaludismeobserved 2015published 2017Malaria journaleurope_pmcdocument of 9 observations

5.3 %The 95th percentile of observed day 3 parasite positivity rate was 5.3% among patients with uncomplicated malaria treated with artemisinin-based combination therapies in Sub-Saharan Africa.

Burkina Fasopaludismepublished 2015BMC medicineeurope_pmcdocument of 11 observations

22 %In the dry season, 186 out of 852 patients with fever (22%) had a Plasmodium falciparum infection in Burkina Faso.

Burkina Fasopaludismeobserved dry seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192

1.48 mosquitoes_per_house_per_nightIn Orodara, the mean nightly Anopheles density increased from 1.48 mosquitoes/house/night.

Burkina FasopaludismeHAL · Unilimdocument of 87 observations

907 casesThere were 907 total confirmed COVID-19 cases in Burkina Faso as of 21 June 2020.

Burkina FasoCOVID-19observed 21 June 2020HAL · Unilimdocument of 97 observations

3 of_12_studiesSalmonella spp. was isolated in three of 12 studies on bloodstream infection in African children under 5 years.

Burkina Fasobloodstream infectionpublished 2016Tropical medicine & international health : TM & IHeurope_pmcdocument of 21 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.